Heart failure trials in Türkiye
12 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2/3RecruitingTrial-stage medicine
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Ankara, Istanbul, Izmir
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085EU 2022-501238-52-00Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Adana, Afyonkarahisar, Ankara, Çorum, Eskişehir, Istanbul, Izmir, Kayseri, Kocaeli, Konya
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459Registry updated 2026-10-29
Phase 3RecruitingTrial-stage medicine
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Adana, Afyonkarahisar, Ankara, Elâzığ, Erzurum, Eskişehir, Gaziantep, Istanbul, Kütahya, Malatya, Mersin, Trabzon
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288EU 2023-509706-30-00Registry updated 2026-10-28
Phase 3RecruitingTrial-stage medicine
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Adana, Erzurum, Eskişehir, Gaziantep, Istanbul, Kütahya, Malatya, Mersin
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370EU 2024-519525-38-00Registry updated 2026-10-28
Phase 3RecruitingTrial-stage medicine
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Adana, Ankara, Bilkent Ankara, Istanbul, Izmir
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952EU 2024-519830-22-00Registry updated 2026-10-27
Phase 3RecruitingTrial-stage medicine
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Adana, Ankara, Bilkent Ankara, Istanbul, Izmir
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805EU 2024-519829-38-00Registry updated 2026-10-15
Phase 3RecruitingResearch participation
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul, Izmir, Kocaeli, Kütahya, Muğla, Sivas
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652EU 2023-508162-15-00Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Adana, Ankara, Antalya, Center, Istanbul, Izmir, Kahramanmaraş, Kütahya, Odunpazari, Yenimahalle
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117EU 2026-526304-79-00Registry updated 2026-09-28
Phase 3RecruitingTrial-stage medicine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa, Çanakkale/Türkiye, Canik/Samsun, Eskişehir, Istanbul, Izmir, Kayseri, Keçiören/Ankara, Kocaeli, Kütahya, Malatya, Merkez/elaziğ, Mersin, Muratpasa/ Antalya, Yakutiye / Erzurum, Yenimahalle/Ankara, Yuregir/Adana
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001EU 2025-523717-29-00Registry updated 2026-08-18
Phase 3RecruitingTrial-stage medicine
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Adana, Ankara, Izmir
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006Registry updated 2026-07-24
No phaseRecruitingResearch participation
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
- Where
- Ankara, Elâzığ, Erzincan, Fatih, Izmir, Kocaeli, Tekirdağ
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Occlutech International AB
See details and how to joinNCT04405583Registry updated 2026-06-08
Phase 3RecruitingTrial-stage medicine
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Adana, Ankara, Izmir
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019Registry updated 2026-05-15
All Heart failure trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.